Early Administration of Intracoronary Verapamil Improves Myocardial Perfusion During Percutaneous Coronary Interventions for Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Early Administration of Intracoronary Verapamil Improves Myocardial Perfusion During Percutaneous Coronary Interventions for Acute Myocardial Infarction

Published:2005-10 Issue:4 Volume:128 Page:2593-2598
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Hang Chi-Ling,Wang Cha-Ping,Yip Hon-Kan,Yang Cheng-Hsu,Guo G. Bih-Fang,Wu Chiung-Jen,Chen Shyh-Ming

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference43 articles.

1. The “no-reflow” phenomenon after temporary occlusion in the dog;Kloner;J Clin Invest,1974

2. Incidence and treatment of “no-reflow” after percutaneous transluminal coronary intervention;Piana;Circulation,1994

3. Features and outcome of no-reflow after percutaneous coronary intervention;Abbo;Am J Cardiol,1995

4. Clinical implications of the “no-reflow” phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction;Ito;Circulation,1996

5. Primary coronary angioplasty in acute myocardial infarction: clinical correlates of the “no-reflow” phenomenon;Marzilli;Int J Cardiol,1998

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Microvascular Obstruction and Intra-Myocardial Hemorrhage in Reperfusion Cardiac Injury. Analysis of Clinical Data;Reviews in Cardiovascular Medicine;2024-03-14

2. Coronary Slow-Flow Phenomenon in Takotsubo Syndrome: The Prevalence, Clinical Determinants, and Long-Term Prognostic Impact;International Journal of Molecular Sciences;2024-01-20

3. Procedural Complications;Complication Management In The Cardiac Catheter Laboratory;2023

4. Prozedurale Komplikationen;Komplikationsmanagement im Herzkatheterlabor;2020

5. A Novel Biological Strategy for Myocardial Protection by Intracoronary Delivery of Mitochondria: Safety and Efficacy;JACC: Basic to Translational Science;2019-12